Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Nikola Hanhoff"'
Autor:
Paul Lauscher, Nikola Hanhoff, Frederik Valbert, Knud Schewe, Christine Koegl, Markus Bickel, Christian Hoffmann, Christoph Stephan, Ramona Pauli, Stefan Preis, Anja Neumann, Eva Wolf
Publikováno v:
AIDS Care. :1-11
Autor:
Daniel Schmidt, Christian Kollan, Barbara Bartmeyer, Viviane Bremer, Tim Schikowski, Martin Friebe, Sven Schellberg, Stefan Scholten, Markus Bickel, Nikola Hanhoff, Robin Rüsenberg, Knud Schewe, NEPOS study group
IntroductionObjectives of this study, as part of a nation-wide HIV pre-exposure prophylaxis (PrEP) evaluation project, were to determine the incidence of infections with HIV, chlamydia, gonorrhea, syphilis, hepatitis A/B/C in persons using PrEP, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83b573b67d3dbf18e82d0b2e5391f2d5
https://doi.org/10.21203/rs.3.rs-1201597/v2
https://doi.org/10.21203/rs.3.rs-1201597/v2
Autor:
Daniel, Schmidt, Christian, Kollan, Barbara, Bartmeyer, Viviane, Bremer, Tim, Schikowski, Martin, Friebe, Sven, Schellberg, Stefan, Scholten, Markus, Bickel, Nikola, Hanhoff, Robin, Rüsenberg, Knud, Schewe, Steve, Rößler
Publikováno v:
Infection.
Objectives of this study, as part of a nation-wide HIV pre-exposure prophylaxis (PrEP) evaluation project, were to determine the incidence of infections with HIV, chlamydia, gonorrhea, syphilis, hepatitis A/B/C in persons using PrEP, and to describe
Autor:
Silke Neusser, Eva Wolf, Knud Schewe, Frederik Valbert, Anja Neumann, Christine Kögl, Nikola Hanhoff, Sven Schellberg, Paul Lauscher, Stefan Preis, Jürgen Wasem, Birgit Mück
Publikováno v:
AIDS Care. 33:1642-1646
Many patients infected with HIV are diagnosed at an advanced stage of illness. These late presenters are individuals with a CD4 cell count of less than 350 cells/µL and/or an AIDS defining disease at initial HIV diagnosis. Purpose of FindHIV is to d
Autor:
Eva Wolf, Anja Neumann, Frederik Valbert, Stefan Preis, Knud Schewe, Nikola Hanhoff, Christian Hoffmann, Kathrin Pahmeier, Stephan Klauke, Jürgen Wasem
Publikováno v:
Value in Health. 23:1324-1331
Objectives The purpose of the prospective clinical and pharmacoeconomic outcomes study of different first-line antiretroviral treatment strategies (PROPHET) was to examine the healthcare costs of human immunodeficiency virus (HIV)–infected persons
Autor:
Daniel Schmidt, Christian Kollan, Barbara Bartmeyer, Viviane Bremer, Tim Schikowski, Martin Friebe, Sven Schellberg, Stefan Scholten, Markus Bickel, Nikola Hanhoff, Robin Rüsenberg, Knud Schewe
IntroductionObjectives of this study, as part of a nation-wide HIV pre-exposure prophylaxis (PrEP) evaluation project, were to determine the incidence and prevalence of infections with HIV, Chlamydia, Gonorrhea, Syphilis, Hepatitis A/B/C in persons u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a448ca5c28778cf0c094fbd1fb00a8f7
https://doi.org/10.21203/rs.3.rs-1201597/v1
https://doi.org/10.21203/rs.3.rs-1201597/v1
Autor:
Jonathan A C Sterne, Margaret T May, Heidi M Crane, Nikola Hanhoff, Jodie L. Guest, Tracy R. Glass, Viviane D. Lima, Michael J. Mugavero, Adriana Ammassari, Jan Tate, M. John Gill, Suzanne M Ingle, Benita Yip, Nicholas L Turner
Publikováno v:
Ingle, S, Crane, H M, Glass, T R, Yip, B, Lima, V D, Gill, M J, Hanhoff, N, Ammassari, A, Mugavero, M J, Tate, J P, Guest, J L, Turner, N, May, M & Sterne, J 2018, ' Identifying risk of viral failure in treated HIV-infected patients using different measures of adherence : the Antiretroviral Therapy Cohort Collaboration ', Journal of Clinical Medicine, vol. 7, no. 10, 328 . https://doi.org/10.3390/jcm7100328
Journal of Clinical Medicine, Vol 7, Iss 10, p 328 (2018)
Journal of Clinical Medicine
Journal of Clinical Medicine; Volume 7; Issue 10; Pages: 328
Journal of Clinical Medicine, Vol 7, Iss 10, p 328 (2018)
Journal of Clinical Medicine
Journal of Clinical Medicine; Volume 7; Issue 10; Pages: 328
Adherence to antiretroviral therapy (ART) is critical for successful treatment of Human Immunodeficiency Virus (HIV), but comparisons across settings are difficult because adherence is measured in different ways. We examined utility of different adhe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79d4934288ee0eeddc24906528de2e1e
https://edoc.unibas.ch/66244/
https://edoc.unibas.ch/66244/
Autor:
Ivanka Krznaric, Nikola Hanhoff, Knud Schewe, Robin Ruesenberg, Christoph D. Spinner, G Knecht, Tim Kuemmerle
Publikováno v:
Infection. 46(3)
To examine current risk behavior, awareness, experience, and attitudes towards pre-exposure-prophylaxis (PrEP), and to estimate a potential impact on the prevention of HIV transmission among HIV-negative MSM in Germany. PrEP was not officially licens
Publikováno v:
Annals of Pharmacotherapy. 49:796-807
Objective: To describe potential drug-drug interactions in the area of HIV/hepatitis C virus (HCV) coinfection and injection drug use, including those between antiretrovirals (ARVs), direct-acting antivirals (DAAs), and opioid-agonist therapy, and to
Autor:
Harald Heider, Cornelia Feiterna-Sperling, Christoph Königs, K. Weizsäcker, Bernd Buchholz, Jörg Hofmann, Josef Eberle, Barbara Gärtner, Nikola Hanhoff, Gundula Notheis, Detlev H. Krüger, Renate Krüger
Publikováno v:
Medical microbiology and immunology. 205(5)
Human herpesvirus-8 (HHV-8) is the etiological agent of Kaposi's sarcoma (KS), which primarily affects human immunodeficiency virus (HIV)-infected adults with advanced immunodeficiency. Currently, only limited prevalence data for HHV-8 infection in H